Literature DB >> 8276185

Gallstone recurrence after shock-wave therapy.

M Sackmann1, H Niller, U Klueppelberg, C von Ritter, J Pauletzki, J Holl, F Berr, M Neubrand, T Sauerbruch, G Paumgartner.   

Abstract

BACKGROUND/AIMS: The long-term outcome of nonoperative gallstone therapy depends on both absence of stones and absence of biliary pain. The aim of the present study was to determine the rate of stone recurrence and the rate of symptoms within 5 years after successful shock wave lithotripsy combined with bile acid therapy.
METHODS: One hundred consecutive patients (single stones, n = 89; 2 or 3 stones, n = 11) were followed up for a median of 4.3 years after stone disappearance and discontinuation of bile acids.
RESULTS: Twenty-three of the 100 patients developed recurrent stones. Calculated by actuarial analysis, the recurrence rate was 7% +/- 3%, 11% +/- 3%, 13% +/- 4%, 20% +/- 5%, and 31% +/- 7% (mean +/- SD) at 1, 2, 3, 4, and 5 years, respectively. The recurrent stones were small (6 +/- 5 mm) and were associated with recurrent biliary pain in 14 (61%) of the 23 patients. Repeated shock wave lithotripsy and/or bile acid medication resulted in stone disappearance in only 10 of 20 patients with recurrence.
CONCLUSIONS: The long-term rate of stone recurrence after lithotripsy of primarily solitary gallbladder calculi is lower than expected from post-bile acid dissolution trials. Recurrence of stones frequently is associated with recurrence of biliary pain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8276185     DOI: 10.1016/s0016-5085(94)95581-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Multifactorial analysis of recurrence of cholecy_stolithiasis in Shanghai area.

Authors:  Pei Chen; Bing-Sheng Wang; Lian-Qi He
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

2.  Sphincter of Oddi dysfunction after successful gallstone lithotripsy (postlithotripsy syndrome): manometric data and results of endoscopic sphincterotomy.

Authors:  T Wehrmann; B Lembcke; W F Caspary; H Seifert
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

3.  Predictions and associations of cholecystectomy in patients with cholecystolithiasis treated with extracorporeal shock wave lithotripsy.

Authors:  H E Adamek; C Rochlitz; A C Von Bubnoff; D Schilling; J F Riemann
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

4.  Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether.

Authors:  J Pauletzki; J Holl; M Sackmann; M Neubrand; U Klueppelberg; T Sauerbruch; G Paumgartner
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

5.  Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.

Authors:  Helen H Wang; Piero Portincasa; Nahum Mendez-Sanchez; Misael Uribe; David Q-H Wang
Journal:  Gastroenterology       Date:  2008-03-10       Impact factor: 22.682

Review 6.  Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.

Authors:  Sreedevi Koppisetti; Bharat Jenigiri; M Pilar Terron; Sandra Tengattini; Hiroshi Tamura; Luis J Flores; Dun-Xian Tan; Russel J Reiter
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

7.  Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?

Authors:  S P Pereira; S H Hussaini; C Kennedy; R H Dowling
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

8.  Therapy of gallstone disease: What it was, what it is, what it will be.

Authors:  Piero Portincasa; Agostino Di Ciaula; Leonilde Bonfrate; David Qh Wang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

Review 9.  Cholecystectomy versus no cholecystectomy in patients with silent gallstones.

Authors:  K S Gurusamy; K Samraj
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

10.  Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease.

Authors:  Ornella de Bari; Brent A Neuschwander-Tetri; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  J Lipids       Date:  2011-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.